Advertisement

Human Papillomavirus Vaccine Uptake: Increase for American Indian Adolescents, 2013–2015

  • Jasmine L. Jacobs-Wingo
    Correspondence
    Address correspondence to: Jasmine L. Jacobs-Wingo, MPH, 42-09 28th St., Long Island City NY 11101
    Affiliations
    Office for State, Tribal, Local, and Territorial Support, Centers for Disease Control and Prevention, Atlanta, Georgia
    Search for articles by this author
  • Cheyenne C. Jim
    Affiliations
    IHRC, Inc., Atlanta, Georgia

    Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
    Search for articles by this author
  • Amy V. Groom
    Affiliations
    Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

    Division of Epidemiology and Disease Prevention, Indian Health Service, Rockville, Maryland
    Search for articles by this author
Published:February 28, 2017DOI:https://doi.org/10.1016/j.amepre.2017.01.024

      Introduction

      Although Indian Health Service, tribally-operated, and urban Indian (I/T/U) healthcare facilities have higher human papillomavirus (HPV) vaccine series initiation and completion rates among adolescent patients aged 13–17 years than the general U.S. population, challenges remain. I/T/U facilities have lower coverage for HPV vaccine first dose compared with coverage for other adolescent vaccines, and HPV vaccine series completion rates are lower than initiation rates. Researchers aimed to assist I/T/U facilities in identifying interventions to increase HPV vaccination series initiation and completion rates.

      Study design

      Best practice and intervention I/T/U healthcare facilities were identified based on baseline adolescent HPV vaccine coverage data. Healthcare professionals were interviewed about barriers and facilitators to HPV vaccination. Researchers used responses and evidence-based practices to identify and assist facilities in implementing interventions to increase adolescent HPV vaccine series initiation and completion. Coverage and interview data were collected from June 2013 to June 2015; data were analyzed in 2015.

      Setting/participants

      I/T/U healthcare facilities located within five Indian Health Service regions.

      Intervention

      Interventions included analyzing and providing feedback on facility vaccine coverage data, educating providers about HPV vaccine, expanding access to HPV vaccine, and establishing or expanding reminder recall and education efforts.

      Main outcome measures

      Impact of evidence-based strategies and best practices to support HPV vaccination.

      Results

      Mean baseline first dose coverage with HPV vaccine at best practice facilities was 78% compared with 46% at intervention facilities. Mean third dose coverage was 48% at best practice facilities versus 19% at intervention facilities. Intervention facilities implemented multiple low-cost, evidence-based strategies and best practices to increase vaccine coverage. At baseline, most facilities used electronic provider reminders, had standing orders in place for administering HPV vaccine, and administered tetanus, diphtheria, and acellular pertussis and HPV vaccines during the same visit. At intervention sites, mean coverage for HPV initiation and completion increased by 24% and 22%, respectively.

      Conclusions

      A tailored multifaceted approach addressing vaccine delivery processes and patient and provider education may increase HPV vaccine coverage.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. IHS Year 2015 Profile. www.ihs.gov/newsroom/factsheets/. Accessed May 4, 2016.

        • Groom A.V.
        • Santibanez T.A.
        • Bryan R.T.
        Vaccination coverage among American Indian and Alaska native children, 2006-2010.
        Pediatrics. 2012; 130: e1592-e1599https://doi.org/10.1542/peds.2012-1001
        • Bridges C.B.
        • Hurley L.P.
        • Williams W.W.
        • Ramakrishnan A.
        • Dean A.K.
        • Groom A.V.
        Meeting the challenges of immunizing adults.
        Am J Prev Med. 2015; 49: S455-S464https://doi.org/10.1016/j.amepre.2015.08.014
      2. Vaccines for Children Program. www.cdc.gov/vaccines/programs/vfc/index.html. Accessed May 4, 2016.

        • Petrosky E.
        • Bocchini Jr., J.A.
        • Hariri S.
        • et al.
        Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 300-304
        • Elam-Evans L.D.
        • Yankey D.
        • Jeyarajah J.
        • et al.
        National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 625-633
        • Schmidt-Grimminger D.C.
        • Bell M.C.
        • Muller C.J.
        • Maher D.M.
        • Chauhan S.C.
        • Buchwald D.S.
        HPV infection among rural American Indian women and urban white women in South Dakota: an HPV prevalence study.
        BMC Infect Dis. 2011; 11: 252https://doi.org/10.1186/1471-2334-11-252
        • Bell M.C.
        • Schmidt-Grimminger D.
        • Patrick S.
        • Ryschon T.
        • Linz L.
        • Chauhan S.C.
        There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains.
        Gynecol Oncol. 2007; 107: 236-241https://doi.org/10.1016/j.ygyno.2007.06.007
        • Watson M.
        • Benard V.
        • Thomas C.
        • Brayboy A.
        • Paisano R.
        • Becker T.
        Cervical cancer incidence and mortality among American Indian and Alaska Native women, 1999-2009.
        Am J Public Health. 2014; 104: S415-S422https://doi.org/10.2105/AJPH.2013.301681
      3. National Immunization Reporting System Reports. 2015. www.ihs.gov/NonMedicalPrograms/ihpes/immunizations/index.cfm?module=immunizations&option=reports. Accessed May 5, 2016.

        • Schmidt-Grimminger D.
        • Frerichs L.
        • Black Bird A.E.
        • Workman K.
        • Dobberpuhl M.
        • Watanabe-Galloway S.
        HPV knowledge, attitudes, and beliefs among Northern Plains American Indian adolescents, parents, young adults, and health professionals.
        J Cancer Educ. 2013; 28: 357-366https://doi.org/10.1007/s13187-013-0468-y
        • Jim C.C.
        • Lee J.W.
        • Groom A.V.
        • et al.
        Human papillomavirus vaccination practices among providers in Indian Health Service, tribal and urban Indian healthcare facilities.
        J Womens Health (Larchmt). 2012; 21: 372-378https://doi.org/10.1089/jwh.2011.3417
        • Daley M.F.
        • Crane L.A.
        • Markowitz L.E.
        • et al.
        Human papillomavirus vaccination practices: a survey of U.S. physicians 18 months after licensure.
        Pediatrics. 2010; 126: 425-433https://doi.org/10.1542/peds.2009-3500
      4. Guide to Community Preventive Services. Increasing appropriate vaccination: health care system-based interventions implemented in combination. www.thecommunityguide.org/findings/vaccination-programs-health-care-system-based-interventions-implemented-combination. Accessed April 16, 2015.

        • Rosenthal S.L.
        • Weiss T.W.
        • Zimet G.D.
        • Ma L.
        • Good M.B.
        • Vichnin M.D.
        Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician’s recommendation.
        Vaccine. 2011; 29: 890-895https://doi.org/10.1016/j.vaccine.2009.12.063
        • Dunne E.F.
        • Markowitz L.E.
        • Saraiya M.
        • et al.
        CDC grand rounds: reducing the burden of HPV-associated cancer and disease.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 69-72
        • Ruffin M.T.
        • Plegue M.A.
        • Rockwell P.G.
        • Young A.P.
        • Patel D.A.
        • Yeazel M.W.
        Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion.
        J Am Board Fam Med. 2015; 28: 324-333https://doi.org/10.3122/jabfm.2015.03.140082
        • Briss P.A.
        • Rodewald L.E.
        • Hinman A.R.
        • et al.
        Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services.
        Am J Prev Med. 2000; 18: 97-140https://doi.org/10.1016/S0749-3797(99)00118-X
        • Szilagyi P.G.
        • Schaffer S.
        • Barth R.
        • et al.
        Effect of telephone reminder/recall on adolescent immunization and preventive visits: results from a randomized clinical trial.
        Arch Pediatr Adolesc Med. 2006; 160: 157-163https://doi.org/10.1001/archpedi.160.2.157
        • Last J.M.
        International Epidemiological Association.
        A Dictionary of Epidemiology. 4th ed. Oxford University Press, New York2001
        • Aschengrau A.
        • Seage G.R.
        Essentials of Epidemiology in Public Health. 2nd ed. Jones and Bartlett Publishers, Sudbury, MA2008
        • Holman D.M.
        • Benard V.
        • Roland K.B.
        • Watson M.
        • Liddon N.
        • Stokley S.
        Barriers to human papillomavirus vaccination among U.S. adolescents: a systematic review of the literature.
        JAMA Pediatr. 2014; 168: 76-82https://doi.org/10.1001/jamapediatrics.2013.2752